Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-25T20:50:02.703Z Has data issue: false hasContentIssue false
  • English
  • Français

Biomimetic Nanohybrids for Combined imaging and Cancer Therapy

Published online by Cambridge University Press:  29 October 2012

A. Topete ,
P. Iglesias ,
M. Alatorre-Meda ,
A. Cambón ,
E. Alvarez ,
J.A. Costoya ,
S. Barbosa ,
P. Taboada  and
V. Mosquera
A. Topete
Affiliation:
Grupo de Física de Coloides y Polímeros
P. Iglesias
Affiliation:
Grupo de Oncología Molecular, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain.
M. Alatorre-Meda
Affiliation:
Grupo de Física de Coloides y Polímeros
A. Cambón
Affiliation:
Grupo de Física de Coloides y Polímeros
E. Alvarez
Affiliation:
Grupo de Física de Coloides y Polímeros
J.A. Costoya
Affiliation:
Grupo de Oncología Molecular, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain.
S. Barbosa
Affiliation:
Grupo de Física de Coloides y Polímeros
P. Taboada
Affiliation:
Grupo de Física de Coloides y Polímeros
V. Mosquera
Affiliation:
Grupo de Física de Coloides y Polímeros
Get access

Abstract

In this work, we have developed a multifunctional theranostic nanoplatform consisting of a poly(lactic-co-glycolic acid) (PLGA) biodegradable matrix covered by a gold shell, which provides the system with NIR absorption ability and subsequent generation of hyperthermia effect. Inside the PLGA nanoparticle, the chemotherapeutic drug doxorubicin (DOXO) and the NIR dye isocyanine green (ICG) were loaded. The characterization of the particles, their in vitro cytotocixity combining NIR light irradiation and chemotherapy and their preliminary in vivo biodistribution is analyzed.

Keywords

absorptioncore/shellbiomedical
Type
Articles
Information
MRS Online Proceedings Library (OPL) , Volume 1468: Symposium VV – Nanomedicine for Molecular Imaging and Therapy , 2012 , mrss12-1468-vv06-05
Copyright
Copyright © Materials Research Society 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Lammers, T., Kiessling, F., Hennink, W.E. and Storm, G., Mol. Pharm. 7, 1899 (2010).10.1021/mp100228vCrossRefGoogle Scholar
Bardhan, R., Lal, S., joshi, A., Halas, N.J., Acc. Chem. Res. 44, 936 (2011).10.1021/ar200023xCrossRefGoogle Scholar
Rao, J., Dragulescu-Andrasi, A., and Yao Curr, H.. Opin. Biotechnol. 18, 17 (2007).CrossRefGoogle Scholar
Maarek, J.M., Holschneider, D.P., Rubinstein, E.H. Anesthesiology 106, 491 (2007).10.1097/00000542-200703000-00013CrossRefGoogle Scholar
Park, H., Yang, J., Seo, S., Kim, K., Suh, J., Kim, D., Haam, S., Yoo, K.H. Small 4, 192 (2008).10.1002/smll.200700807CrossRefGoogle Scholar
Lee, S.-M., Park, H., Yoo Adv, K.-H.. Mater. 22, 4049 (2010).Google Scholar
Lee, S.-M., Park, H., Choi, J.-W., Park, Y.N., Yun, C.-O., Yoo, K.-H. Angew. Chem. Int. Ed. 50, 7581 (2011).10.1002/anie.201101783CrossRefGoogle Scholar
Jain, R.J., Biomaterials 21, 2475 (2000).10.1016/S0142-9612(00)00115-0CrossRefGoogle Scholar
Pavlukhina, S., Sukhishvili, S. Adv. Drug Deliv. Rev. 63, 822 (2011).CrossRefGoogle Scholar
Brinson, B.E., Lassiter, J.B., Levin, C.S., Bardhan, R., Mirin, N., Halas, N.J. Langmuir 24, 14166 (2008).10.1021/la802049pCrossRefGoogle Scholar
Liu, H., chen, D., Li, L., Liu, T., Tan, L., Wu, X., and Tang, F., Angew. Chem. Int. Ed. 50, 891 (2011).10.1002/anie.201002820CrossRefGoogle Scholar
Hauck, T.S., Jennings, T.L., Yasenko, T., Kumaradas, J.C., and Chan, W.C.W. Adv. Mater. 20, 3832 (2008)10.1002/adma.200800921CrossRefGoogle Scholar